Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
24.07.25
/
50%
€20.00
Target price
24.07.26
€28.88
Performance (%)
-7.65%
Price
16:19
€18.47
Summary
This prediction is currently active. With a performance of -7.65%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 24.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 1.320% | 1.320% |
| iShares Core DAX® | 2.850% | 3.312% |
| iShares Nasdaq 100 | 1.612% | 5.652% |
| iShares Nikkei 225® | 6.401% | 11.958% |
| iShares S&P 500 | 1.346% | 4.130% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.17
29.09.25
29.09.25
€28.15
29.09.26
29.09.26
1.65%
16:19
16:19
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
-4.20%
16:19
16:19
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
25.03.24
25.03.24
€23.06
25.03.25
25.03.25
-4.67%
26.03.25
26.03.25